Category Archives: Uncategorized

Hello, The Latest News in Herpes Advocacy is here. Enjoy reading the latest news? Want to see progress faster? Support our work today. Healthy Volunteers Needed for BNT163-01 Clinical TrialContinueContinue reading “Updates from the Pipeline, IHW 2023 and more news!”

Advocates Town Hall Meeting: Herpes advocates town hall meetings are open to patients, professionals, and those looking to get involved to make a difference. We’ll discuss Herpes Cure Advocacy urgentContinueContinue reading “Register: Herpes Advocates Town Hall Meeting June 1”

Herpes Clinical Pipeline AiCuris Non-Confidential Slide Deck May 2023: AiCuris planning for commercial launch of Priteliver 2025. Launch prep for Priteliver is ongoing. Innovative Molecules advances IM-250: The clinical trialContinueContinue reading “Progress for a Cure for Herpes Continues”

BDGene Therapeutics is a Chinese biotech company based in Shanghai. BDgene now has approval to run Phase 3 trials (held in China) on their gene therapy cure for HSV-1 keratitis.ContinueContinue reading “Herpes Keratitis Cure advances to Phase 3 Clinical Trials in China”

Herpes Cure Advocacy celebrates a step forward on the path to the cure, treatment and prevention of Herpes. NIH has assembled a Multi-Council Working Group for Herpes Simplex Virus andContinueContinue reading “NIH forms Multi-Council Working Group for Herpes”

Herpes Cure Advocacy News HHS Listening Sessions: Two listening sessions were held this past week in an effort to gather insights for an addendum to the HHS 2020 STI StrategicContinueContinue reading “Latest Updates on Herpes Cure Treatment and Prevention”

Mark your calendars! The HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) wants to hear from members of the STI community during two virtual listening sessions on April 4th and AprilContinueContinue reading “Advocacy Alert: Registration Open for OASH Listening Sessions”

Positive news abounds for the Aicuris team, and patients living with HSV, with the release of new results from their Phase three clinical trials for Pritelivir and initiation of aContinueContinue reading “Promising Progress in clinical trials for Pritelivir”

The Centers for Disease Control and Prevention (CDC), the Office of Science (OS) in late December 2022 issued a Broad Agency Announcement (BAA) for the competitive selection of research proposals,ContinueContinue reading “CDC issues Request for Proposal to develop new serology test for Herpes Simplex Virus”

Hyundai Biosciences have applied for a clinical study in Korea to test the efficacy of CP-COVO3, a new candidate treatment for viral infections, on HPV. This antiviral agent, developed inContinueContinue reading “New Clinical Study for Broad spectrum anti-viral to treat HPV, Mpox, and possibly herpes”